CAS and Westlake University collaborate on ‘Trailblazing the Future with Emerging Biomaterials’ report

This June, CAS, a division of the American Chemical Society, together with Westlake University, released the research report “Trailblazing the Future with Emerging Biomaterials.” The report was developed as a service to the global scientific information community. Its intent is to provide data-informed analysis for those who may be interested in biomedical materials, including business leaders, investors, and policymakers. With the recent growth in published science, the volume and complexity of scientific information is escalating. This report addresses that complexity in the area of biomaterials. The foundational data in the report leverage the CAS Content Collection, which covers more than 50,000 scientific journals in over 50 languages, 279 million substances, and key invention details from applications published by 109 global patent authorities. Using advanced data tools and big data analytics, the report uncovers emerging trends and comprehensive landscape views of biomaterials research. This approach provides the latest discoveries, advancements, and

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-09-23
DOI
https://doi.org/10.1021/cen-10229-acsnews2
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CAS and Westlake University collaborate on ‘Trailblazing the Future with Emerging Biomaterials’ report

Sara Cottle
C&EN Global Enterprise
Biomedical Ethics and Regulation
article

CAS and Westlake University collaborate on ‘Trailblazing the Future with Emerging Biomaterials’ report

Sara Cottle
article en

Abstract

This June, CAS, a division of the American Chemical Society, together with Westlake University, released the research report “Trailblazing the Future with Emerging Biomaterials.” The report was developed as a service to the global scientific information community. Its intent is to provide data-informed analysis for those who may be interested in biomedical materials, including business leaders, investors, and policymakers. With the recent growth in published science, the volume and complexity of scientific information is escalating. This report addresses that complexity in the area of biomaterials. The foundational data in the report leverage the CAS Content Collection, which covers more than 50,000 scientific journals in over 50 languages, 279 million substances, and key invention details from applications published by 109 global patent authorities. Using advanced data tools and big data analytics, the report uncovers emerging trends and comprehensive landscape views of biomaterials research. This approach provides the latest discoveries, advancements, and

C&EN Global EnterpriseVol. 102(29)
Openalex Percentile: Top 78%
Biomedical Ethics and Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.